Listed

Celularity Inc: Form 10-K for the period ended Dec 31, 2019

Filed with the SEC on Mar 24, 2020 and accepted by EDGAR at Mar 23, 2020, 19:48 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating income12 months2019-01-01 to 2019-12-31−$564.3kus-gaap:OperatingIncomeLoss
Income tax12 months2019-01-01 to 2019-12-31$668.2kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2019-01-01 to 2019-12-31$2.5mus-gaap:NetIncomeLoss
Diluted EPS12 months2019-01-01 to 2019-12-31−$0.03us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2019-01-01 to 2019-12-31−$1.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2019-12-31$917.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-12-31$1.0mus-gaap:AssetsCurrent
Total assetsAt period end2019-12-31$291.6mus-gaap:Assets
Current liabilitiesAt period end2019-12-31$229.1kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-12-31$11.0mus-gaap:Liabilities
Shareholders' equityAt period end2019-12-31$5.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-20-007185. Last ingested by Listed: Nov 11, 2026, 02:51 ET. Listed shows no prices and gives no investment advice.